1618
J. Kalisiak, J. Jurczak
LETTER
(15) 19-Benzyloxy-18-bromo-2,8,14-trioxa-5,11-diaza-
(8) (a) Vögtle, F.; Meurer, K.; Mannschreck, A.; Stühler, G.;
Puff, H.; Roloff, A.; Sievers, R. Chem. Ber. 1983, 116,
2630. (b) Kang, G. J.; Chan, T. H. J. Org. Chem. 1985, 50,
452. (c) Meurer, K.; Luppertz, F.; Vögtle, F. Chem. Ber.
1985, 118, 4433. (d) Grimme, S.; Pischel, I.; Vögtle, F.;
Nieger, M. J. Am. Chem. Soc. 1995, 117, 157.
bicyclo[13.3.1]nonadeca-1 (18),15 (19),16-triene-4,12-
dione (11). Purified by column chromatography (silica gel,
EtOAc) to give 11 (1720 mg, 72%) as a white solid; mp
172.6–173.6 °C. 1H NMR (500 MHz, CDCl3): d = 8.59–8.53
(br d, 1 H, NHCO), 7.99–7.93 (br d, 1 H, NHCO), 7.58–7.54
(m, 2 H), 7.46–7.41 (m, 3 H), 7.37 (d, J = 9 Hz, 1 H), 6.81
(d, J = 9 Hz, 1 H), 5.06 (dAB, J = 9.5 Hz, CH2Ph, 1 H), 4.99
(dAB, J = 9.5, CH2Ph, 1 H), 4.89 (dA1B1, J = 16.5, CH2CO, 1
H), 4.82 (dA2B2, J = 16.1 Hz, CH2CO, 1 H), 4.63 (dA1B1, J =
16.5 Hz, CH2CO, 1 H), 4.52 (dA2B2, J = 16.1 Hz, CH2CO),
3.80–3.71 (m, 2 H), 3.19–3.10 (m, 3 H), 3.04–2.99 (m, 1 H),
2.96–2.88 (m, 1 H), 2.64–2.57 (m, 1 H). 13C NMR (125
MHz, CDCl3): d = 168.5, 168.1, 153.0, 151.3, 142.5, 134.9,
130.2, 129.8, 129.3, 128.8, 115.5, 109.1, 78.5, 73.8, 72.5,
69.3, 69.1, 38.9, 38.8. HR–ESI (MeOH): m/z [M + Na]+
calcd for C21H23N2O679BrNa: 501.0632; found: 501.0646.
Anal. Calcd for C21H23N2O6Br: C, 52.62; H, 4.84; N, 5.84;
Br, 16.67. Found: C, 52.49; H, 4.93; N, 5.63; Br, 16.52.
(16) Piątek, P.; Kalisiak, J.; Jurczak, J. Tetrahedron Lett. 2004,
45, 3309.
(e) Hochmuth, D. H.; König, W. A. Liebigs Ann. 1996, 947.
(f) Müller, D.; Böhme, M.; Nieger, M.; Rissanen, K.; Vögtle,
F. J. Chem. Soc., Perkin Trans. 1 1996, 2937. (g) Grimme,
S.; Harren, J.; Sobański, A.; Vögtle, F. Eur. J. Org. Chem.
1998, 1491. (h) Iwamoto, H.; Yang, Y.; Usui, S.; Fukazawa,
Y. Tetrahedron Lett. 2001, 42, 49. (i) Es, D. S.; Gret, N.;
Rijke, M.; Eis, M. J.; Kanter, F. J. J.; Wolf, W. H.;
Bickelhaupt, F.; Menzer, S.; Spek, A. L. Tetrahedron 2001,
57, 3557.
(9) (a) Schmidtchen, F. P.; Berger, M. Chem. Rev. 1997, 97,
1609. (b) Kubik, S.; Goddard, R. J. Org. Chem. 1999, 64,
9475. (c) Piątek, P.; Jurczak, J. Chem. Commun. 2002,
2450. (d) Bondy, C. R.; Loeb, S. J. Coord. Chem. Rev. 2003,
240, 77. (e) Choi, K.; Hamilton, A. D. Coord. Chem. Rev.
2003, 240, 101.
(10) (a) Gryko, D. T.; Gryko, D.; Jurczak, J. Synlett 1999, 1310.
(b) Piątek, P.; Gruza, M. M.; Jurczak, J. Tetrahedron:
Asymmetry 2001, 12, 1763.
(11) General Procedure for Synthesis of Macrocyclic
Compounds 10–12: To a mixture of appropriate ester (5
mmol) and appropriate amine (5 mmol) in anhyd MeOH (60
mL) was added solution of MeONa (12.5 mmol) in anhyd
MeOH (50 mL). The mixture was left at r.t. for several hours
(monitored by TLC). The solvent was evaporated and the
residue was purified by column chromatography.
(17) 11-Bromo-26-(1-naphthylmethoxy)-2,8,15,21-tetraoxa-
5,18-diaza-tricyclo[20.3.1.0*9,14*]hexacosa-1 (25),9
(14),10,12,22 (26),23-hexaene-4,19-dione (12). Purified by
column chromatography (silica gel, EtOAc) to give 12 (465
mg, 15%) as white solid; mp 166.5–167.8 °C. 1H NMR (500
MHz, CDCl3): d = 8.30–8.26 (m, 1 H), 7.98–7.93 (m, 2 H,
NHCO), 7.85–7.80 (m, 1 H), 7.74–7.67 (m, 2 H), 7.52–7.47
(m, 2 H), 7.35–7.30 (m, 1 H), 7.13 (t, 1 H, J = 8.4), 6.89 (dd,
1 H, J1 = 8.6 Hz, J2 = 2.2 Hz), 6.79–6.74 (m, 2 H), 6.55 (d, 1
H, J = 2.2 Hz), 6.36 (d, 1 H, J = 8.6 Hz), 5.47 (s, 2 H,
CH2Naph), 4.79 (ddAB, J1 = 8.2 Hz, J2 = 15.6 Hz, 2 H,
CH2CO), 4.58 (dAB, J = 15.6 Hz, 2 H, CH2CO), 3.90–3.80
(m, 2 H), 3.71–3.65 (m, 1 H), 3.62–3.52 (m, 3 H), 3.38–3.30
(m, 2 H). 13C NMR (125 MHz, CDCl3): d = 168.7, 168.6,
153.4, 153.3, 148.3, 146.8, 139.3, 133.5, 132.0, 131.5,
129.5, 128.9, 127.1, 126.4, 125.8, 125.7, 125.1, 123.4,
123.2, 115.4, 112.9, 112.7, 111.2, 111.0, 74.2, 70.9, 70.7,
67.3, 67.2, 38.6, 38.5. HR–ESI (MeOH): m/z [M + Na]+
calcd for C31H29N2O779BrNa: 643.1050, found: 643.1039.
Anal. Calcd for C31H29N2O7Br: C, 59.91; H, 4.70; N, 4.51;
Br, 12.86. Found: C, 60.01; H, 4.84; N, 4.38; Br, 12.74.
(18) HPLC analyses for 11 and 12. Column: Chiralcel OD-H®,
length 250 mm; i.d. 4.6 mm. For 11: i-PrOH–hexane, 3:1;
flow rate 0.7 mL/min.; l = 254 nm. For 12: i-PrOH–hexane,
1:1; flow rate 1.1 mL/min.; l = 254 nm. Enantiomeric
purities obtained: (+)11: 93% ee, [a]D26 = +61.8 (c = 0.56,
CHCl3); (–)11: 88% ee, [a]D26 –59.3 (c = 0.55, CHCl3);
(+)12: 99% ee, [a]D26 = +18.9 (c = 0.37, CHCl3); (–)12: 94%
ee, [a]D26 –17.9 (c = 0.37, CHCl3).
(12) Yu, M. J.; McCowan, J. R.; Phebus, L. A.; Towner, R. D.;
Ho, P. P. K.; Keith, P. T.; Luttman, C. A.; Saunders, R. D.;
Ruterbories, K. J.; Lindstrom, T. D.; Wikel, J. H.; Morgan,
E.; Hahn, R. A. J. Med. Chem. 1993, 36, 1262.
(13) 19-Benzyloxy-2,8,14-trioxa-5,11-diaza-
bicyclo[13.3.1]nonadeca-1 (18),15 (19),16-triene-4,12-
dione (10). Purified by column chromatography (silica gel,
EtOAc) to give 10 (60%) as a white solid; mp 183.9–184.5
°C. 1H NMR (500 MHz, DMSO-d6): d = 7.82–7.76 (m, 2 H,
NHCO), 7.60 (d, J = 7.0 Hz, 2 H), 7.48 (t, J = 7.0 Hz, 2 H),
7.43–7.39 (m, 1 H), 7.16 (dd, J1 = 1.9 Hz, J2 = 7.3 Hz, 1 H),
7.09 (d, J = 7.8 Hz, 2 H), 5.04 (s, 2 H, CH2Ph), 4.76 (dAB
J = 16.5 Hz, 2 H, CH2CO), 4.69 (dAB, J = 16.5 Hz, 2 H,
,
CH2CO), 3.52–3.43 (m, 2 H), 3.12–3.05 (m, 4 H), 2.87–2.82
(m, 2 H). 13C NMR (125 MHz, DMSO-d6): d = 167.9, 152.7,
139.4, 136.1, 128.8, 128.7, 128.6, 128.5, 125.9, 125.7,
113.4, 113.2, 76.7, 71.3, 68.4, 38.6. HR–ESI (MeOH): m/z
[M + Na]+ calcd for C21H24N2O6Na: 423.1532; found:
423.1542. Anal. Calcd for C21H24N2O6: C, 63.00; H, 6.00; N,
7.00. Found: C, 63.10; H, 6.01; N, 7.06.
(19) CD experiments were measured in MeCN in a 0.1 cm cell at
24 °C.
(14) Gryko, D. T.; Piątek, P.; Jurczak, J. Tetrahedron 1997, 53,
7957.
Synlett 2004, No. 9, 1616–1618 © Thieme Stuttgart · New York